Empower Clinic Services, LLC dba Empower Pharmacy

Warning LetterOpen

Recipient Title Founder & Chief Executive Officer, Empower Clinic Services, LLC dba Empower Pharmacy, 7601 N. Sam Houston Pkwy W., Ste. 100 Houston , TX 77064-3595 United States, (b)(4)Issued Sep 18, 2026Center for Drug Evaluation and Research (CDER)

View Letter

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy.

Violations7

Issue DateSep 18, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Empower Clinic Services, LLC dba Empower Pharmacy
Location: Recipient Title Founder & Chief Executive Officer, Empower Clinic Services, LLC dba Empower Pharmacy, 7601 N. Sam Houston Pkwy W., Ste. 100 Houston , TX 77064-3595 United States, (b)(4)
FEI Number: N/A
Country: United States
Issue Date: September 18, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug

Empower Clinic Services, LLC dba Empower Pharmacy FDA Warning Letter, September 18, 2026